11 – 20 of 49
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Minimal clinically important differences for Dyspnea-12 and MDP scores are similar at 2 weeks and 6 months : follow-up of a longitudinal clinical study
(
- Contribution to journal › Letter
-
Mark
Nasal symptoms increase the risk of snoring and snoring increases the risk of nasal symptoms. A longitudinal population study
(
- Contribution to journal › Article
-
Mark
Association of cardiometabolic risk factors with hospitalisation or death due to COVID-19 : population-based cohort study in Sweden (SCAPIS)
(
- Contribution to journal › Article
-
Mark
ERS/EAACI statement on adherence to international adult asthma guidelines
(
- Contribution to journal › Scientific review
-
Mark
The ratio FEV1/FVC and its association to respiratory symptoms—A Swedish general population study
(
- Contribution to journal › Article
- 2020
-
Mark
Management and risk of mortality in patients hospitalised due to a first severe COPD exacerbation
(
- Contribution to journal › Article
-
Mark
Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality : A nationwide cohort study of the global SABINA programme
(
- Contribution to journal › Article
-
Mark
Minimal Clinically Important Differences and Feasibility of Dyspnea-12 and the Multidimensional Dyspnea Profile in Cardiorespiratory Disease
(
- Contribution to journal › Article
-
Mark
Assessment of Global Lung Function Initiative (GLI) reference equations for diffusing capacity in relation to respiratory burden in the Swedish CArdioPulmonary bioImage Study (SCAPIS)
(
- Contribution to journal › Article
-
Mark
Chronic airflow limitation and its relation to respiratory symptoms among ever-smokers and never-smokers : a cross-sectional study
(
- Contribution to journal › Article